NEW YORK (GenomeWeb News) – Following Hologic's $3.7 billion agreement to acquire Gen-Probe, the molecular diagnostics space may be on the verge of some industry consolidation, according to investment analysts.

Yesterday, Hologic announced the $82.75 per-share offer for Gen-Probe, concluding a search Gen-Probe began a year ago for a buyer. The deal has some industry observers considering which other MDx firms may be ripe for a deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.